Thrombolysis With Intravenous Tissue Plasminogen Activator Predicts a Favorable Discharge Disposition in Patients With Acute Ischemic Stroke | Zendy

Nneka L. Ifejika | Zendy; Nusrat Harun | Zendy; Nareesa A Mohammed-Rajput | Zendy; Elizabeth A. Noser | Zendy; James C. Grotta | Zendy

Open Access

Thrombolysis With Intravenous Tissue Plasminogen Activator Predicts a Favorable Discharge Disposition in Patients With Acute Ischemic Stroke

Author(s) -

Nneka L. Ifejika,

Nusrat Harun,

Nareesa A Mohammed-Rajput,

Elizabeth A. Noser,

James C. Grotta

Publication year - 2011

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.110.604108

Subject(s) - medicine , thrombolysis , stroke (engine) , rehabilitation , tissue plasminogen activator , emergency medicine , acute care , t plasminogen activator , physical therapy , health care , myocardial infarction , mechanical engineering , economic growth , engineering , economics

Acute ischemic stroke patients who receive recombinant tissue plasminogen activator (rt-PA) within 3 hours of symptom onset are 30% more likely to have minimal to no disability at 3 months. During hospitalization, short-term disability is subjectively measured by discharge disposition, whether to home, inpatient rehabilitation, a skilled nursing facility, or subacute care. There are no studies assessing the role of recombinant tissue plasminogen activator use as a predictor of poststroke discharge disposition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research